Established in 2011 in North Carolina USA, Lucerno Technologies is the world leader in the Design, Development, Manufacture and Distribution of systems to detect the presence of radiolabelled biomarkers and radiopharmaceuticals. Developing start of the art miniaturized PET and SPECT sensors allows the Lara System to determine whether a radiopharmaceutical has been injected correctly into a patients vein as opposed to the surrounding tissue. The Lara System brings added safety to the patient and attending staff and importantly ensure the physician of the reliability, accuracy and sensitivity of the subsequent PET or SPECT scan.

Patient Safety/Dosimetry and Quality in Radiopharmaceutical Administrations

Immunotherapy assessment

Parkinson’s Disease evaluation

Rheumatoid Arthritis quantification